ACADIA Pharmaceuticals, Inc. (ACAD)
21.76
-0.26
(-1.18%)
USD |
NASDAQ |
Apr 15, 16:00
21.72
-0.04
(-0.18%)
After-Hours: 06:17
ACADIA Pharmaceuticals Research and Development Expense (Quarterly) : 84.76M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 254.91M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Merck & Co., Inc. | 2.499B |
| Axsome Therapeutics, Inc. | 48.68M |
| Marker Therapeutics, Inc. | 2.141M |